Table 1 Estimated unit costs of screening, diagnosis, treatment prescription, and enhanced adherence counseling interventions and estimates of the 2016 coverage levels and estimated spend; estimates of the unit costs of providing treatment (insulin and oral) and patient monitoring according to protocols, along with estimates of the number of people in need of each monitoring treatment and monitoring type, and the cost of meeting those needs (disaggregated costs are contained in Table S2). Notes: (1) IEC = Information Education Communication; (2) PHC = Primary Health Clinic
Unit cost (USD) | Estimated number who received service | Estimated spend (USD) | |
|---|---|---|---|
Screening tests | 45,636 | 30,003 | |
Facility-based blood glucose test | 0.66 | 41,833 | 27,503 |
Outreach/community-based blood glucose test | 0.66 | 3803 | 2500 |
Diagnosis (confirmatory test) | 3344 | 12,708 | |
Oral glucose tolerance tests | 3.80 | 3344 | 12,708 |
Treatment prescription protocols | 3090 | 8163 | |
IEC1 through residential school/courses | 5.76 | 773 | 4451 |
IEC through PHC2 clinic staff | 1.60 | 2318 | 3712 |
Adherence counseling | 2085 | ||
Enhanced adherence counseling at PHC clinic | 0.62 | 2339 | 1439 |
Enhanced adherence counseling at Feldsher post | 0.55 | 1170 | 646 |
Estimated number in need of service | Cost of meeting needs (USD) | ||
Treatment maintenance | 40,000 | 6,097,737 | |
Annual co-payments for oral medication | 34.30 | 31,067 | 1,065,523 |
Annual co-payments for insulin | 356.56 | 8600 | 3,066,413 |
Annual patient monitoring costs | 40,000 | 1,965,801 | |
Non-pharma, glucose controlled | 24.48 | 960 | 23,504 |
Non-pharma, not achieving glucose target | 28.28 | 2240 | 63,356 |
Oral, glucose controlled | 25.61 | 8460 | 216,678 |
Oral, not achieving glucose target | 52.85 | 19,740 | 1,043,278 |
Insulin, glucose controlled | 48.97 | 1978 | 96,858 |
Insulin, not achieving glucose target | 78.85 | 6622 | 522,126 |